These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26293294)

  • 1. Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection.
    Park TE; Mohamed A; Kalabalik J; Sharma R
    Expert Rev Anti Infect Ther; 2015; 13(10):1195-212. PubMed ID: 26293294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dolutegravir: a new integrase strand transfer inhibitor for the treatment of HIV.
    Shah BM; Schafer JJ; Desimone JA
    Pharmacotherapy; 2014 May; 34(5):506-20. PubMed ID: 24347095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection.
    Rathbun RC; Lockhart SM; Miller MM; Liedtke MD
    Ann Pharmacother; 2014 Mar; 48(3):395-403. PubMed ID: 24259658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection.
    Zhao AV; Crutchley RD; Guduru RC; Ton K; Lam T; Min AC
    Retrovirology; 2022 Oct; 19(1):22. PubMed ID: 36273165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug safety profile of integrase strand transfer inhibitors.
    Gutierrez Mdel M; Mateo MG; Vidal F; Domingo P
    Expert Opin Drug Saf; 2014 Apr; 13(4):431-45. PubMed ID: 24597519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium.
    Nguyen BY; Isaacs RD; Teppler H; Leavitt RY; Sklar P; Iwamoto M; Wenning LA; Miller MD; Chen J; Kemp R; Xu W; Fromtling RA; Vacca JP; Young SD; Rowley M; Lower MW; Gottesdiener KM; Hazuda DJ
    Ann N Y Acad Sci; 2011 Mar; 1222():83-9. PubMed ID: 21434946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?
    Brooks KM; Sherman EM; Egelund EF; Brotherton A; Durham S; Badowski ME; Cluck DB
    Pharmacotherapy; 2019 May; 39(5):576-598. PubMed ID: 30860610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrase strand transfer inhibitors in the management of HIV-positive individuals.
    Mesplède T; Quashie PK; Zanichelli V; Wainberg MA
    Ann Med; 2014 May; 46(3):123-9. PubMed ID: 24579911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary resistance to integrase strand-transfer inhibitors in Europe.
    Casadellà M; van Ham PM; Noguera-Julian M; van Kessel A; Pou C; Hofstra LM; Santos JR; Garcia F; Struck D; Alexiev I; Bakken Kran AM; Hoepelman AI; Kostrikis LG; Somogyi S; Liitsola K; Linka M; Nielsen C; Otelea D; Paraskevis D; Poljak M; Puchhammer-Stöckl E; Staneková D; Stanojevic M; Van Laethem K; Zidovec Lepej S; Clotet B; Boucher CA; Paredes R; Wensing AM;
    J Antimicrob Chemother; 2015 Oct; 70(10):2885-8. PubMed ID: 26188038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dolutegravir: a next-generation integrase inhibitor for treatment of HIV infection.
    Osterholzer DA; Goldman M
    Clin Infect Dis; 2014 Jul; 59(2):265-71. PubMed ID: 24723281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting.
    d'Arminio Monforte A; Cozzi-Lepri A; Di Biagio A; Marchetti G; Lo Caputo S; Rusconi S; Gianotti N; Mazzotta V; Mazzarello G; Costantini A; Castagna A; Antinori A;
    J Antimicrob Chemother; 2019 May; 74(5):1363-1367. PubMed ID: 30698801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Mechanism of Resistance of Human Immunodeficiency Virus Type 2 to Integrase Inhibitors: A 5-Amino-Acid Insertion in the Integrase C-Terminal Domain.
    Le Hingrat Q; Collin G; Lê M; Peytavin G; Visseaux B; Bertine M; Tubiana R; Karmochkine M; Valin N; Collin F; Lemaignen A; Bernard L; Damond F; Matheron S; Descamps D; Charpentier C;
    Clin Infect Dis; 2019 Aug; 69(4):657-667. PubMed ID: 30383215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrase Strand Transfer Inhibitors (INSTIs) Resistance Mutations in HIV-1 Infected Turkish Patients.
    Sayan M; Gündüz A; Ersöz G; İnan A; Deveci A; Özgür G; Sargın F; Karagöz G; İnci A; İnan D; Ülçay A; Karaoğlan I; Kaya S; Kutlu SS; Süer K; Çağatay A; Akalın H
    HIV Clin Trials; 2016 May; 17(3):109-13. PubMed ID: 27125365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Pathways Conferring Integrase Strand-Transfer Inhibitors Resistance.
    Richetta C; Tu NQ; Delelis O
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors.
    Podany AT; Scarsi KK; Fletcher CV
    Clin Pharmacokinet; 2017 Jan; 56(1):25-40. PubMed ID: 27317415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence.
    Mesplède T; Wainberg MA
    Viruses; 2015 Jul; 7(7):3703-18. PubMed ID: 26198244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dolutegravir - a review of the pharmacology, efficacy, and safety in the treatment of HIV.
    Kandel CE; Walmsley SL
    Drug Des Devel Ther; 2015; 9():3547-55. PubMed ID: 26185421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergent drug resistance with integrase strand transfer inhibitor-based regimens.
    Lepik KJ; Harrigan PR; Yip B; Wang L; Robbins MA; Zhang WW; Toy J; Akagi L; Lima VD; Guillemi S; Montaner JSG; Barrios R
    AIDS; 2017 Jun; 31(10):1425-1434. PubMed ID: 28375875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Antiretroviral Agents: Potent Integrase Inhibitors.
    Psichogiou M; Poulakou G; Basoulis D; Paraskevis D; Markogiannakis A; Daikos GL
    Curr Pharm Des; 2017; 23(18):2552-2567. PubMed ID: 28356041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New first and second generation inhibitors of human immunodeficiency virus-1 integrase.
    Pendri A; Meanwell NA; Peese KM; Walker MA
    Expert Opin Ther Pat; 2011 Aug; 21(8):1173-89. PubMed ID: 21599420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.